Quantitative Systematic Strategies LLC Glycomimetics Inc Transaction History

Quantitative Systematic Strategies LLC

  • $0
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 15, 2019
SELL
$9.96 - $13.44 $206,729 - $278,960
-20,756 Closed
0 $0
Q4 2018

Feb 12, 2019
BUY
$8.47 - $14.71 $52,657 - $91,452
6,217 Added 42.76%
20,756 $197,000
Q3 2018

Nov 14, 2018
SELL
$13.7 - $17.12 $25,208 - $31,500
-1,840 Reduced 11.23%
14,539 $209,000
Q2 2018

Aug 07, 2018
BUY
$14.63 - $19.19 $239,624 - $314,313
16,379 New
16,379 $264,000

Others Institutions Holding GLYC

# of Institutions
35
Shares Held
17.8M
Call Options Held
0
Put Options Held
0
View Full List

About GLYCOMIMETICS INC

GLYC Quotes by TradingView
  • Ticker GLYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,423,900
  • Market Cap $16.8M
  • Description
  • GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...
More about GLYC
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email